FDA inspection
Lupin Pharmaceuticals Inc.: FDA inspection ending Feb 27, 2007
FDA inspection 461556 · Voluntary Action Indicated (VAI) · Baltimore, MD
Key facts
| Inspection ID | 461556 |
|---|---|
| Firm | Lupin Pharmaceuticals Inc. |
| FEI number | 3004097115 |
| Address | Harborplace Tower, 111 S Calvert St Fl 21st |
| City | Baltimore |
| State | MD |
| ZIP | 21202-6174 |
| Fiscal year | 2007 |
| Inspection end date | Feb 27, 2007 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Post Mrkt Surv & Epid: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data